Effect of CGP 36742 on the extracellular level of neurotransmitter amino acids in the thalamus

Neurochemistry International

Volumn 34, Issue 5, 1999, Pages 391-398

  Nyitrai, Gabriella ^a   Szárics, Éva ^a   Kovács, Ilona ^a   Kékesi, Katalin A ^b   Juhász, Gábor ^b   Kardos, Julianna ^a  

^a CHEMICAL RESEARCH CENTER   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPYLBUTYLPHOSPHINIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ASPARTIC ACID; BACLOFEN; DIZOCILPINE; GLUTAMIC ACID; GLYCINE; NEUROTRANSMITTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL MEMBRANE; CONFERENCE PAPER; CONTROLLED STUDY; FLUORESCENCE; IN VITRO STUDY; INTRACEREBRAL DRUG ADMINISTRATION; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; ASPARTIC ACID; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; EXTRACELLULAR SPACE; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLYCINE; KINETICS; MALE; MICRODIALYSIS; NEUROTRANSMITTER AGENTS; ORGANOPHOSPHORUS COMPOUNDS; RATS; RATS, WISTAR; RECEPTORS, GABA-B; TAU PROTEINS; THALAMUS;

EID: 0344224277     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(99)00042-X     Document Type: Conference Paper

References (20)

1. Benveniste H., Huttemeier P.C. Microdialysis: theory application. Prog. Neurobiol. 35:1990;195-215.
2. Bridges R.J., Stanley M.S., Anderson M.W., Cotman C.W., Chamberlin A.R. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J. Med. Chem. 34:1991;717-725.
3. Carletti R., Libri V., Bowery N.G. The GABAb Antagonist CGP 36742 enhances spatial learning performance and antagonises baclofen-induced amnesia in mice. Brit. J. Pharmacol. 109:(Suppl. 74):1993.
4. Crunelli V., Emri Zs, Leresche N., Kékesi K.A., Soltész I., Toth K., Turner J., Juhász G. GABAb receptors in the ventrobasal thalamus assessed by in vivo and in vitro experiments. Pharmacol. Comm. 2:1992;113-116.
5. Haugland R.P. Handbook of Fluorescent Probes and Research Chemicals. 1996;572-573 Molecular Probes, Inc, Leiden.
6. Honoré T., Davies S.N., Drejer J., Fletcher E.J., Jacobsen P., Lodge D., Nielson N.E. Quinoxalinediones: potent competitive non-NMDA receptor antagonists. Science. 241:1988;701-703.
7. Jones E.G. The Thalamus. 1985;Plenum Press, New York.
8. Juhász G., Tarcali J., Pungor K., Pungor E. Electrochemical calibration of in vivo brain dialysis samplers. J. Neurosci. Methods. 29:1989;131-137.
9. Kardos J., Kovács I., Blandl T., Cash D.J. Modulation of GABA flux across rat brain membranes resolved by a rapid quenched incubation technique. Neurosci. Lett. 182:1994;73-76.
10. Kardos J., Blandl T., Kovács I., Kékesi K.A., Reichart A., Nyitrai G., Dobolyi Á, Juhász G. Use of ligands with low nanomolar affinity to the GABAb receptor: the effect of CGP 55845A on the release of amino acids. Pharm. Rev. Comm. 8:1996;153-157.
11. Katz B., Miledi R. The role of calcium action during neuromuscular function. J. Physiol. Lond. 189:1967;535-544.
12. ++ in brain plasma membrane vesicles. Neurochem. Int. 33:1998;399-405.
13. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
14. Mondadory C., Möbius H.J., Borkowski J. The GABAb receptor antagonist CGP 36742 and the nootropic oxiracetam facilitate the formation of long-term memory. Behav. Brain Res. 77:1996;223-225.
15. Nyitrai G., Emri Zs, Crunellli V., Kékesi A.K., Dobolyi Á, Juhász G. Blockade of thalamic GABAb receptors in vivo increases excitatory amino acid levels. Eur. J. Pharmacol. 318:1996;295-300.
16. Pellegrino L.J., Cushman A.J. A Stereotaxic Atlas of the Rat Brain. 1967;Appleton-Century-Crofts, New York.
17. Salt T.E. Modulation of NMDA receptor mediated responses by glycine and D-serine in the rat thalamus in vivo. Brain Res. 481:1989;403-406.
18. Serfõzõ P., Cash D.J. Glutamate receptor (α-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate subtype) activity enhanced by dizocilpine (MK801) in rat hippocampus. Eur. J. Biochem. 228:1995;498-505.
19. Shimizu H., Graham S.H., Chang L.H., Mintorovitcch J., James T.L., Faden A.I., Weinstein P.R. Relationship between extracellular neurotransmitter amino acids and energy metabolism during cerebral ischemia in rats monitored by microdialysis and in vivo magnetic resonance spectroscopy. Brain Res. 605:1993;33-42.
20. Wong E.H., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulstant MK801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA. 83:1986;7104-7108.